DELCATH SYSTEMS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.91 USD | 0.00% |
|
-2.35% | +90.14% |
| Jun. 28 | Delcath Systems Files Mixed Shelf Registration | MT |
| May. 28 | Delcath Systems, Inc. Appoints Bridget Martell to Board of Directors | CI |
Presentation Operator MessageOperator (Operator)Good day, ladies and gentlemen. And welcome to...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT) percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. HEPZATO KIT is a drug/device combination product designed to administer high-dose chemotherapy directly into the liver while limiting systemic exposure and associated side effects. In Europe, the hepatic delivery system is a stand-alone medical device having the same device components as HEPZATO KIT, but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT. In the United States, HEPZATO is regulated as a drug by the United States Food and Drug Administration (FDA).
Calendar
2024-08-05
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
7.91
USD
Average target price
20.67
USD
Spread / Average Target
+161.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +90.14% | 220M | |
| -13.13% | 20.34B | |
| +6.72% | 13.86B | |
| +1.62% | 9.32B | |
| -28.73% | 1.82B | |
| +8.56% | 1.82B | |
| +5.57% | 1.3B | |
| -2.09% | 514M | |
| 0.00% | 334M | |
| +25.74% | 106M |
- Stock Market
- Equities
- DCTH Stock
- News Delcath Systems, Inc.
- Transcript : Delcath Systems, Inc., Q2 2014 Earnings Call, Aug 06, 2014
